학술논문
Long-term neuroprotective effects of natalizumab and fingolimod in multiple sclerosis: Evidence from real-world clinical data
Document Type
Article
Author
Source
In Multiple Sclerosis and Related Disorders July 2024 87
Subject
Language
ISSN
2211-0348